MARKETS
Earnings

Xylem Raises FY2026 Adj EPS Guidance from $5.35-$5.60 to $5.55-$5.70 vs $5.54 Est; Narrows FY2026 Sales Guidance from $9.200B-$9.300B to $9.200B vs $9.254B Est

Jul 28, 2026 · 06:56 AM ET· updated 4h ago

Xylem (NYSE:XYL) raises FY2026 Adj EPS guidance from $5.35-$5.60 to $5.55-$5.70 vs $5.54 analyst estimate. Narrows FY2026 sales outlook from $9.200 billion-$9.300 billion to $9.200 billion vs $9.254 billion estimate.

Share
Why It Matters

Xylem expects to make more profit per share than before, which is good news. But they also expect sales to be slightly lower than what experts thought, so it's a mixed picture of what's ahead.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.